Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -9.148% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) COc1ccccc1/C=C1\Oc2cc(OC(=O)N3CCOCC3)ccc2C1=O
b) C=CCN1C(=O)OC2(CCCCC2)C1(C)O
c) CCC(C)(C)NC(=O)C1CCC(CNS(=O)(=O)c2cccc3nsnc23)CC1
d) COc1cccc(/C=N/NC(=O)c2ccccc2)c1OS(=O)(=O)c1ccccc1
e) O=c1[nH]n(-c2ccc(Cl)cc2)c(=O)c(Cl)c1Cl
Answer: c. CCC(C)(C)NC(=O)C1CCC(CNS(=O)(=O)c2cccc3nsnc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)NC(=O)C1CCC(CNS(=O)(=O)c2cccc3nsnc23)CC1
CCC(C)(C)NC(=O)C1CCC(CNS(=O)(=O)c2cccc3nsnc23)CC1
4-[(2,1,3-benzothiadiazol-4-ylsulfonylamino)methyl]-N-(2-methylbutan-2-yl)cyclohexane-1-carboxamide